DR. DANIEL YIN WU, M.D., PH.D.
Osteopathic Medicine in Seattle, WA

License number
Washington MD00031148
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address 2
1660 S COLUMBIAN WAY 111-ONC, Seattle, WA 98108
4907 136Th Pl SE, Bellevue, WA 98006
Phone
(206) 764-2709
(206) 764-2851 (Fax)
(425) 957-0308

Personal information

See more information about DANIEL YIN WU at radaris.com
Name
Address
Phone
Daniel Wu, age 63
4907 136Th Pl SE, Bellevue, WA 98006
Daniel Wu, age 62
732 Lingering Pine Dr NW, Issaquah, WA 98027
Daniel Wu, age 62
13313 23Rd Pl NE, Seattle, WA 98125
Daniel Wu
2310 185Th Pl NE, Redmond, WA 98052
Daniel T Wu, age 62
2310 185Th Pl NE, Redmond, WA 98052

Professional information

Daniel Wu Photo 1

Program Manager At Microsoft

Position:
Program Manager, Windows Azure Group at Microsoft
Location:
Greater Seattle Area
Industry:
Computer Software
Work:
Microsoft - Redmond, Washington since Jan 2013 - Program Manager, Windows Azure Group Microsoft - Redmond, Washington Feb 2011 - Dec 2012 - Software Design Engineer in Test, Active Directory Division Microsoft - Redmond, WA Aug 2006 - Feb 2011 - Software Design Engineer in Test, Connected Systems Division VMware - Palo Alto, CA Sep 2005 - Dec 2005 - Software Developer Intern, Performance Group
Education:
Pennsyvania State University 2009 - 2011
MBA
University of Waterloo 2001 - 2006
Software Engineering
Skills:
Software Engineering, Visual Studio, Distributed Systems, .NET, C#, Software Development, Agile Methodologies, Test Automation, Windows Identity Foundation, Windows Communication Foundation, SSL Certificates, Identity Federation


Daniel Wu Photo 2

Project Management Consultant

Position:
Project Management Consultant at YNW Consulting
Location:
Greater Seattle Area
Industry:
Information Technology and Services
Work:
YNW Consulting since Feb 2003 - Project Management Consultant
Education:
University of Washington, Michael G. Foster School of Business 2006 - 2007
Oxford
Skills:
E-commerce, SEO, Strategy


Daniel Y Wu Photo 3

Dr. Daniel Y Wu - MD (Doctor of Medicine)

Hospitals:
1660 S Columbian Way, Seattle 98108
1660 S Columbian Way, Seattle 98108


Daniel Wu Photo 4

Sequence Variants Of Multi-Drug Resistance Genes, Mdr1 And Mrp1, And Methods For Assessment Of Drug Penetration And Disposition

US Patent:
7445897, Nov 4, 2008
Filed:
Jan 26, 2005
Appl. No.:
11/045578
Inventors:
Ziping Yang - Shoreline WA, US
Danny D. Shen - Edmonds WA, US
Daniel Wu - Bellevue WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C12Q 1/68, G01N 1/30, G01N 33/48
US Classification:
435 6, 435 405
Abstract:
Provided are compositions relating to novel MDR1 polymorphisms, including nucleic acids, polypeptides, and recombinant cells, as well as methods for detection of MDR1 polymorphisms in biological samples and elucidation of the influence of MDR1 polymorphisms on MDR1 protein function. Also provided are a rat MRP1 cDNA and protein, stable cell lines expressing the rat MRP1 protein, and methods of assessing drug penetration or disposition in a cell line expressing a recombinant mammalian MRP1 or MDR1 protein, or a homolog thereof.


Daniel Wu Photo 5

Novel Sequence Variants Of Multi-Drug Resistance Genes, Mdr1 And Mrp1, And Recombinant Cells Expressing Mrp1 And Mdr1 For Assessment Of Drug Penetration And Disposition

US Patent:
2009013, May 21, 2009
Filed:
Sep 26, 2008
Appl. No.:
12/239514
Inventors:
Rodney J.Y. Ho - Seattle WA, US
Ziping Yang - Shoreline WA, US
Danny D. Shen - Edmonds WA, US
Daniel Wu - Bellevue WA, US
Assignee:
WASHINGTON, UNIVERSITY OF - Seattle WA
International Classification:
C12Q 1/02, C12N 15/11, C12N 15/00, C12N 5/06
US Classification:
435 29, 536 231, 4353201, 435325, 435350
Abstract:
Provided are compositions relating to novel MDR1 polymorphisms, including nucleic acids, polypeptides, and recombinant cells, as well as methods for detection of MDR1 polymorphisms in biological samples and elucidation of the influence of MDR1 polymorphisms on MDR1 protein function. Also provided are a rat MRP1 cDNA and protein, stable cell lines expressing the rat MRP1 protein, and methods of assessing drug penetration or disposition in a cell line expressing a recombinant mammalian MRP1 or MDR1 protein, or a homolog thereof.